
Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk
Feb 14, 2024 - 00:11:56
Radio and PodcastLive Radio & Podcasts
The last two years have provided updated guidelines on management of chronic kidney disease in type 2 diabetes alongside new regulatory approvals of pharmacotherapies. In this episode we speak to Dr David Cherney about t...
Focus on CKD: Latest guidelines and therapies With Dr David Cherney is an episode from Diabetes Knowledge into Practice Podcast by Liberum IME. The last two years have provided updated guidelines on management of chronic kidney disease in t...
This episode belongs to Diabetes Knowledge into Practice Podcast.
Use the player on this page to stream the episode online.
Published Aug 22, 2022, 00:18:26 long, audio available.
The last two years have provided updated guidelines on management of chronic kidney disease in type 2 diabetes alongside new regulatory approvals of pharmacotherapies. In this episode we speak to Dr David Cherney about the implications of these updates and advancements. By completing this activity, you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at , where you can find all past episodes of the podcast as well as other free CME resources. References available here Disclosures: Dr David Cherney declares the following financial relationships from the past 24 months: Honoraria: Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, BMS, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo-Nordisk Grant/Research support: Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring, and Novo-Nordisk. Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose. The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity. Funding: This independent educational activity is supported by an educational grant from Eli Lilly. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Eli Lilly has had no influence on the content of this education.
You can listen to Focus on CKD: Latest guidelines and therapies With Dr David Cherney online on Radio and Podcast. Open the player on this page to stream the available audio.
Focus on CKD: Latest guidelines and therapies With Dr David Cherney is an episode from Diabetes Knowledge into Practice Podcast by Liberum IME.
This episode is 00:18:26 long.
This episode was published on Aug 22, 2022.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Diabetes Knowledge into Practice Podcast when more episodes are available from the podcast feed.
You can listen to Focus on CKD: Latest guidelines and therapies With Dr David Cherney on this page when the episode audio is available from the podcast feed.
Focus on CKD: Latest guidelines and therapies With Dr David Cherney is from Diabetes Knowledge into Practice Podcast by Liberum IME.
Published Aug 22, 2022 and 00:18:26 long